Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Vera Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +13 vs. Q4 2021
- Shares held
- 19.7M
- +5.62M (+40.0%) vs. Q4 2021
- Total value
- $468.9M
- +$94.0M (+25.1%) vs. Q4 2021
- New holders
- 15
- 23 more added
- Sold out
- 2
- 8 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $3.34B |
| Q1 2026 | 229 | $2.92B |
| Q4 2025 | 214 | $3.75B |
| Q3 2025 | 176 | $1.89B |
| Q2 2025 | 172 | $1.51B |
| Q1 2025 | 179 | $1.52B |
| Q4 2024 | 178 | $2.66B |
| Q3 2024 | 173 | $2.37B |
| Q2 2024 | 171 | $1.92B |
| Q1 2024 | 159 | $2.21B |
| Q4 2023 | 95 | $637.2M |
| Q3 2023 | 84 | $538.2M |
| Q2 2023 | 76 | $611.9M |
| Q1 2023 | 70 | $289.7M |
| Q4 2022 | 59 | $412.8M |
| Q3 2022 | 55 | $459.0M |
| Q2 2022 | 51 | $277.6M |
| Q1 2022 | 50 | $468.9M |
| Q4 2021 | 37 | $374.9M |
| Q3 2021 | 31 | $252.4M |
| Q2 2021 | 22 | $186.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 227 | $5.00K | 0.00% | −311−57.8% | Reduced |
| US Bancorp | 1,000 | $23.0K | 0.00% | +1,000 | New |
| Metropolitan Life Insurance Co | 1,041 | $24.5K | 0.00% | +1,041 | New |
| Ameritas Investment Partners, Inc. | 1,061 | $25.0K | 0.00% | +519+95.8% | Added |
| Legal & General Group Plc | 1,307 | $31.0K | 0.00% | +374+40.1% | Added |
| Royal Bank of Canada | 1,341 | $32.0K | 0.00% | −1,355−50.3% | Reduced |
| Amalgamated Bank | 1,438 | $34.0K | 0.00% | +1,438 | New |
| Amalgamated Financial Corp. | 1,438 | $34.0K | 0.00% | +1,438 | New |
| STRS Ohio | 1,600 | $37.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,009 | $47.0K | 0.00% | +2,009 | New |
| Barclays PLC | 2,222 | $53.0K | 0.00% | +2,222 | New |
| Wells Fargo & Company | 2,955 | $69.0K | 0.00% | −2,742−48.1% | Reduced |
| California State Teachers Retirement System | 5,850 | $137.0K | 0.00% | +434+8.0% | Added |
| American International Group, Inc. | 6,794 | $160.0K | 0.00% | +1,535+29.2% | Added |
| Deutsche Bank AG | 8,104 | $191.0K | 0.00% | +2,091+34.8% | Added |
| MetLife Investment Management | 8,881 | $208.6K | 0.00% | +8,881 | New |
| Cambridge Trust Co | 9,887 | $232.0K | 0.01% | 00.0% | Unchanged |
| Rhumbline Advisers | 10,385 | $244.0K | 0.00% | +10,385 | New |
| Citigroup Inc | 10,895 | $256.0K | 0.00% | +8,238+310.0% | Added |
| New York State Common Retirement Fund | 10,983 | $258.0K | 0.00% | +4,434+67.7% | Added |
| Ensign Peak Advisors, Inc | 13,277 | $312.0K | 0.00% | +13,277 | New |
| Bank of America Corp | 15,604 | $367.0K | 0.00% | +3,697+31.0% | Added |
| Carnegie Mellon University | 16,060 | $377.0K | 0.16% | −16,060−50.0% | Reduced |
| Gyon Technologies Capital Management, LP | 16,961 | $398.0K | 0.28% | −7,592−30.9% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 17,828 | $419.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 18,518 | $435.0K | 0.00% | −8,173−30.6% | Reduced |
| Charles Schwab Investment Management Inc | 34,743 | $817.0K | 0.00% | +11,251+47.9% | Added |
| Nuveen Asset Management, LLC | 53,623 | $1.14M | 0.00% | +38,525+255.2% | Added |
| Bank of New York Mellon Corp | 48,836 | $1.15M | 0.00% | +28,247+137.2% | Added |
| Polar Asset Management Partners Inc. | 60,000 | $1.41M | 0.02% | +60,000 | New |
| Maven Securities LTD | 64,240 | $1.51M | 0.31% | +64,240 | New |
| Northern Trust Corp | 109,407 | $2.57M | 0.00% | +31,554+40.5% | Added |
| Millennium Management LLC | 133,500 | $3.14M | 0.00% | +133,500 | New |
| JPMorgan Chase & Co | 149,601 | $3.51M | 0.00% | +73,475+96.5% | Added |
| State Street Corp | 168,757 | $3.96M | 0.00% | +45,484+36.9% | Added |
| Geode Capital Management, LLC | 202,547 | $4.76M | 0.00% | +80,965+66.6% | Added |
| Alphabet Inc. | 301,580 | $7.08M | 0.23% | −412,078−57.7% | Reduced |
| Baker Bros. Advisors LP | 333,333 | $7.83M | 0.04% | +333,333 | New |
| Logos Global Management LP | 385,000 | $9.04M | 1.17% | +335,000+670.0% | Added |
| International Biotechnology Trust PLC | 190,749 | $11.6M | 5.10% | +70,214+58.3% | Added |
| Kynam Capital Management, LP | 502,328 | $11.8M | 3.84% | +248,879+98.2% | Added |
| Octagon Capital Advisors LP | 575,000 | $13.5M | 2.92% | −95,940−14.3% | Reduced |
| Vanguard Group Inc | 618,003 | $14.5M | 0.00% | +229,025+58.9% | Added |
| Vivo Capital, LLC | 666,666 | $15.7M | 1.08% | +666,666 | New |
| BlackRock Inc. | 679,675 | $16.0M | 0.00% | +224,575+49.3% | Added |
| Ra Capital Management, L.P. | 1,966,084 | $46.2M | 1.01% | +1,966,084 | New |
| Citadel Advisors LLC | 2,089,520 | $49.1M | 0.06% | +356,338+20.6% | Added |
| Abingworth LLP | 2,960,231 | $69.3M | 19.66% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,181,442 | $74.7M | 6.28% | +266,666+9.1% | Added |
| FMR LLC | 4,012,030 | $94.2M | 0.01% | +866,828+27.6% | Added |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −21,555−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −8,287−100.0% | Sold out |